ES2083319A1 - Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. - Google Patents

Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.

Info

Publication number
ES2083319A1
ES2083319A1 ES09301981A ES9301981A ES2083319A1 ES 2083319 A1 ES2083319 A1 ES 2083319A1 ES 09301981 A ES09301981 A ES 09301981A ES 9301981 A ES9301981 A ES 9301981A ES 2083319 A1 ES2083319 A1 ES 2083319A1
Authority
ES
Spain
Prior art keywords
benzisothiazol
indole
dihydro
chloro
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301981A
Other languages
English (en)
Other versions
ES2083319B1 (es
Inventor
Douglas J M Allen
Frank R Busch
Sabeto A Diroma
Dennis M Godek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to ES9301981A priority Critical patent/ES2083319B1/es
Publication of ES2083319A1 publication Critical patent/ES2083319A1/es
Application granted granted Critical
Publication of ES2083319B1 publication Critical patent/ES2083319B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

MONOHIDRATO DE CLORHIDRATO DE 5-(2-(4-(1,2-BENZISOTIAZOL-3-IL)-1-PIPERAZINIL)-ETIL)-6-CLORO-1,3-DIHIDRO-2H-INDOL-2-ONA. EL MONOHIDRATO DE CLORHIDRATO DE 5-(2-(4-(1,2-BENZISOTIAZOL-3-IL)-1-PIPERAZINIL)-ETIL)-6-CLORO-1,3-DIHIDRO-2H-INDOL-2-ONA TIENE LA VENTAJA DE SU ESTABILIDAD PARA SU FORMULACION COMO AGENTE NEUROLEPTICO.
ES9301981A 1993-09-20 1993-09-20 Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. Expired - Fee Related ES2083319B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301981A ES2083319B1 (es) 1993-09-20 1993-09-20 Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301981A ES2083319B1 (es) 1993-09-20 1993-09-20 Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.

Publications (2)

Publication Number Publication Date
ES2083319A1 true ES2083319A1 (es) 1996-04-01
ES2083319B1 ES2083319B1 (es) 1997-01-16

Family

ID=8283083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301981A Expired - Fee Related ES2083319B1 (es) 1993-09-20 1993-09-20 Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.

Country Status (1)

Country Link
ES (1) ES2083319B1 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281309A1 (en) * 1987-03-02 1988-09-07 Pfizer Inc. Piperazinyl-heterocyclic compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0586191A1 (en) * 1992-09-01 1994-03-09 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281309A1 (en) * 1987-03-02 1988-09-07 Pfizer Inc. Piperazinyl-heterocyclic compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0586191A1 (en) * 1992-09-01 1994-03-09 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride

Also Published As

Publication number Publication date
ES2083319B1 (es) 1997-01-16

Similar Documents

Publication Publication Date Title
CA2105114A1 (en) Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-Yl)-1- Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-Indol-2-One Hydrochloride
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
AP2001002066A0 (en) Substituted oxazoles and thiazoles derivatives at hPPAR gamma and hPPAR alpha activators
AU666413B2 (en) Antiallergic composition for opthalmic or nasal use
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
BG102893A (en) Mesylate trihadrated salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1 ,3-dihydro-2(1h)-indol-2-on (=ciprazidon), its preparation and application as dopamine d2 antagonist
JO2239B1 (en) Method for preparing benzothophen derivatives
FI956279L (fi) Menetelmiä ja välituotteita 5-/2-(4-(bentsoisotiatsol-3-yyli)piperatsin-1-yyli)etyyli/-6-kloori-1,3-dihydroindol-2-onin valmistamiseksi
WO1999009025A3 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
WO2000027832A3 (en) Thiazole derivatives as ppar gamma ligands
NO940274D0 (no) 2-(4-(-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler
CA2244621A1 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
PL348601A1 (en) New pharmaceutical composition and the process for its preparation
GR3035033T3 (en) Heterocyclic chemistry
MY109504A (en) Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
ES8504185A1 (es) Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina
AU779761C (en) Medicament for treatment of neuropathies
GB0021784D0 (en) Novel pharmaceutical
FI942159A7 (fi) Menetelmä 2-(4-(4-(4-kloori-1-pyratsolyyli)butyyli)-1-piperatsinyyli)pyrimidiinin (lesopitron) valmistamiseksi
ES2083319B1 (es) Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona.
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
ES2062940A1 (es) Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930920

Kind code of ref document: B1

Effective date: 19930920

FD2A Announcement of lapse in spain

Effective date: 20141120